Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer

O'Callaghan, Dermot S., Rexhepaj, Elton, Gately, Kathy, Coate, Linda, Delaney, David, O'Donnell, Dearbhaile M., Kay, Elaine, O'Connell, Finbarr, Gallagher, William M., & O'Byrne, Kenneth J. (2015) Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer. European Respiratory Journal, 46, pp. 1762-1772.

[img] Accepted Version (PDF 539kB)
Administrators only until June 2017 | Request a copy from author

View at publisher


The impact of host immunity on outcome in nonsmall cell lung cancer (NSCLC) is controversial. We examined the relationship between lymphoid infiltration patterns in NSCLC and prognosis.

Tumour- and stroma-infiltrating CD3+, CD8+ and forkhead box P3 (Foxp3)+ T-lymphocytes were identified using immunohistochemistry and a novel image analysis algorithm to assess total, cytotoxic and regulatory T-lymphocyte counts, respectively, in 196 NSCLC cases. The median cell count was selected as a cut-point to define patient subgroups and the ratio of the corresponding tumour islet:stroma (TI/S) counts was determined.

There was a positive association between overall survival and increased CD8+ TI/S ratio (hazard ratio (HR) for death 0.44, p<0.001) but an inverse relationship between Foxp3+ TI/S ratio and overall survival (HR 4.86, p<0.001). Patients with high CD8+ islet (HR 0.48, p<0.001) and Foxp3+ stromal (HR 0.23, p<0.001) counts had better survival, whereas high CD3+ and CD8+ stromal counts and high Foxp3+ islet infiltration conferred a worse survival (HR 1.55, 2.19 and 3.14, respectively). By multivariate analysis, a high CD8+ TI/S ratio conferred an improved survival (HR 0.48, p=0.002) but a high Foxp3+ TI/S ratio was associated with worse survival (HR 3.91, p<0.001).

Microlocalisation of infiltrating T-lymphocytes is a powerful predictor of outcome in resected NSCLC.

Impact and interest:

2 citations in Scopus
Search Google Scholar™
1 citations in Web of Science®

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 95214
Item Type: Journal Article
Refereed: Yes
Keywords: NSCLC, immunohistochemistry, lung cancer, survival
DOI: 10.1183/13993003.00176-2014
ISSN: 0903-1936
Divisions: Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Deposited On: 27 Apr 2016 23:04
Last Modified: 01 May 2016 04:31

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page